Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AAV directed hLDLR gene therapy----[1] 79
2AAV2-GDNF gene therapy----[1] 17
3AB-1001 Gene Therapy----[1] 8
4Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)[1] Adenosine[1] D00045 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 65
5Gene therapy----[1] 65
6Gene Therapy Method for CGD----[1] 65
7Gene Therapy product:vMCO-I----[1] 90
8Gene Therapy-vMCO-010----[1] 301
9Intracerebral LV gene therapy----[1] 20
10Lymphocyte gene therapy----[1] 19
11OTL-200 Gene Therapy----[1] 19
12Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy----[1] 79
13TgAAC94 gene therapy vector----[2] 46, 271
14X vivo gene therapy----[1] 65